A Phase II study of Axitinib as maintenance for patients with advanced colorectal carcinoma.
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Axitinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms TTD-11-01
- 11 Oct 2016 Results assessing efficacy and safety presented at the 41st European Society for Medical Oncology Congress.
- 20 Apr 2016 Status changed from active, no longer recruiting to discontinued due to absence of patients recruitment.
- 18 Nov 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.